长风药业2月27日斥资118.01万港元回购3.05万股
Group 1 - The company, Changfeng Pharmaceutical (02652), announced a share buyback on February 27, 2026, for a total expenditure of HKD 1.1801 million [1] - The buyback involved repurchasing 30,500 shares [1]
Group 1 - The company, Changfeng Pharmaceutical (02652), announced a share buyback on February 27, 2026, for a total expenditure of HKD 1.1801 million [1] - The buyback involved repurchasing 30,500 shares [1]